Jounce Therapeutics, Inc. JNCE
1.88 +1.88
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2022 · select a line to chart its full history
Income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 82.00M | 26.91M | 62.34M | 147.87M | 65.20M | |
| 82.00M | 26.91M | 62.34M | 147.87M | 65.20M | |
| -52.24M | -91.06M | -45.12M | 52.82M | -31.29M | |
| -50.92M | -90.87M | -43.84M | 56.82M | -27.38M | |
| -0.99 | -1.82 | -1.24 | 1.66 | -0.84 |
Balance sheet
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 150.57M | 95.53M | 147.49M | 53.24M | 47.91M | |
| 212.55M | 252.70M | 244.24M | 205.88M | 214.45M | |
| 29.44M | 28.89M | 32.94M | 31.29M | 110.32M | |
| 10.02M | 13.69M | 16.89M | 19.79M | 0 | |
| 183.11M | 223.81M | 211.29M | 174.59M | 104.13M |
Cash flow
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| -28.88M | -83.49M | -27.79M | -30.13M | -63.61M | |
| 83.48M | -60.51M | 51.30M | 31.38M | 86.41M | |
| 442.00K | 92.04M | 70.74M | 4.08M | 1.55M | |
| -919.00K | -373.00K | -94.00K | -985.00K | -1.36M | |
| 55.04M | -51.96M | 94.25M | 5.33M | 24.35M |